No connection

Search Results

TONX

BEARISH
$2.5 Live
TON Strategy Co · NASDAQ
$1.75 52W Range $29.77
Overview AI Snowflake Price Valuation Profitability Growth Health Statements Peers Insiders SEC Filings

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 21, 2026
Market cap
$147.73M
P/E
N/A
ROE
-70.3%
Profit margin
N/A
Debt/Equity
0.0
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
95%
TONX exhibits critical fundamental weakness, highlighted by a Piotroski F-Score of 1/9, indicating severe financial distress. Despite a massive 694% YoY revenue growth, the company suffers from an operating margin of -99.51% and a catastrophic 5-year price decline of 100%. The combination of bearish insider selling ($3M in sales) and a history of extreme quarterly losses suggests a highly speculative and unstable entity.

Key Strengths

Exceptional YoY revenue growth (694.20%)
Strong short-term liquidity (Current Ratio 9.23)
Zero reported debt (Debt/Equity 0.00)
Recent trend of narrowing EPS losses
Trading significantly below book value (P/B 0.35)

Key Risks

Extreme operational inefficiency (Operating Margin -99.51%)
Severe historical price collapse (-100% over 5 years)
Strong bearish insider sentiment with consistent director selling
Lack of consistent profitability and negative ROE (-70.26%)
High Price-to-Sales ratio (11.56) for a non-profitable company

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
15
Weak
Value
20
Future
40
Past
5
Health
10
Dividend
0
AI Verdict
High Risk / Speculative
Key drivers: Piotroski F-Score 1/9, Negative Operating Margins, Insider Divestment, Historical Price Decay
Confidence
90%
Value
20/100

Ref P/E N/A, P/B 0.35, Graham Number None

Positives
  • Low Price-to-Book (0.35)
Watchpoints
  • No P/E or Graham Number due to lack of earnings
  • High P/S ratio relative to profitability
Future
40/100

Ref Revenue Growth 694.20%

Positives
  • Hyper-growth in revenue
  • Improving EPS surprise trend
Watchpoints
  • Unsustainable burn rate
  • Lack of analyst coverage/targets
Past
5/100

Ref 5Y Change -100%

Positives
No standout positives identified.
Watchpoints
  • 5Y Change -100%
  • History of massive quarterly EPS misses
Health
10/100

Ref Piotroski F-Score 1/9

Positives
  • Zero Debt
  • High Current Ratio
Watchpoints
  • Piotroski F-Score 1/9
  • Negative ROE/ROA
Dividend
0/100

Ref Yield N/A

Positives
No standout positives identified.
Watchpoints
  • No dividend history
  • 0/100 Dividend Strength

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$2.5

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for TONX and closest competitors.

Updated 2026-04-20
TON
TON Strategy Co
Primary
5Y
-100.0%
3Y
-99.5%
1Y
-42.5%
6M
-39.8%
1M
-15.2%
1W
+4.2%
SPW
SunPower Inc.
Peer
5Y
-88.3%
3Y
-88.6%
1Y
-39.5%
6M
-29.8%
1M
-0.8%
1W
+1.7%
THR
Thryv Holdings, Inc.
Peer
5Y
-87.5%
3Y
-86.0%
1Y
-72.2%
6M
-72.2%
1M
+17.6%
1W
+10.8%
IDN
Intellicheck, Inc.
Peer
5Y
-11.2%
3Y
+222.0%
1Y
+222.0%
6M
+58.3%
1M
+61.0%
1W
-2.7%
SAN
Sangoma Technologies Corporation
Peer
5Y
-82.0%
3Y
+10.5%
1Y
-11.9%
6M
-15.7%
1M
-5.0%
1W
+12.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
0.35
P/S Ratio
11.56
EV/Revenue
7.98
EV/EBITDA
-3.12
Market Cap
$147.73M

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin -99.51%
Gross Margin 69.53%
ROE -70.26%
ROA -9.56%

Growth

Revenue and earnings growth rates

Revenue Growth +694.2%
Earnings Growth N/A
Q/Q Revenue Growth +694.19%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.0
Low debt
Current Ratio
9.23
Strong
Quick Ratio
8.86
Excellent
Cash/Share
$0.7

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Gross Margin
64.3%
Op. Margin
-104.7%
Net Margin
-3968.6%
Total Assets
$0.4B
Liabilities
$0.0B
Equity
$0.4B
Debt/Equity
0.01x
Operating CF
$-0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
100%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-13
$N/A
2025-11-12
$2.23
+217.4% surprise
2025-08-06
$-1.79
+12.2% surprise
2025-05-13
$-2.51
+16.1% surprise

Technology Sector Comparison

Comparing TONX against 490 companies in the Technology sector (40 bullish, 167 neutral, 283 bearish)
Return on Equity (ROE)
-70.26%
This Stock
vs
-34.81%
Sector Avg
+101.8% (Excellent)
Debt to Equity
0.0
This Stock
vs
0.71
Sector Avg
-99.9% (Less Debt)
Revenue Growth
694.2%
This Stock
vs
5058.57%
Sector Avg
-86.3% (Slower)
Current Ratio
9.23
This Stock
vs
3.77
Sector Avg
+145.2% (Stronger)

Similar Companies

Peer comparison within the same industry

TONX TON Strategy Co
BEARISH
Mkt Cap
$148M
P/E
-
ROE
-70.3%
Price
$2.5
SPWR SunPower Inc.
BEARISH
Mkt Cap
$149M
P/E
-
ROE
-%
Price
$1.18
 Compare with TONX
THRY Thryv Holdings, Inc.
BEARISH
Mkt Cap
$144M
P/E
327.0
ROE
0.1%
Price
$3.27
 Compare with TONX
IDN Intellicheck, Inc.
BEARISH
Mkt Cap
$154M
P/E
108.6
ROE
6.6%
Price
$7.6
 Compare with TONX
SANG Sangoma...
BEARISH
Mkt Cap
$140M
P/E
-
ROE
-2.2%
Price
$4.2
 Compare with TONX

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

CUTAIA RORY J
Director
Sell
2025-12-16
88,626 shares · $227,569
CUTAIA RORY J
Director
Sell
2025-12-12
151,449 shares · $462,047
CUTAIA RORY J
Director
Sell
2025-12-05
78,600 shares · $271,771
CUTAIA RORY J
Director
Sell
2025-12-05
78,600 shares · $272,360
CUTAIA RORY J
Director
Sell
2025-12-02
177,749 shares · $561,606
CUTAIA RORY J
Director
Sell
2025-11-26
390,940 shares · $1,203,461
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
8-K
2026-04-16
8-K/A
8-K/A
2026-04-02

Tonix Pharmaceuticals Holding Corp. filed an amendment to a previously submitted current report.

8-K
8-K
2026-03-31

Tonix Pharmaceuticals reported its first-quarter financial results for the period ending March 31, 2026.

10-K
10-K
2026-03-31

TONX filed its 10-K annual report on March 31, 2026. The provided excerpts do not contain specific financial highlights or risk disclosures to evaluate the company's current performance or risk profile.

8-K
8-K
2026-03-26
8-K
8-K
2026-03-02
8-K
8-K
2026-01-28
8-K
8-K
2025-11-12
10-Q
10-Q
2025-11-12

TONX's 10-Q for the period ended September 30, 2025, indicates significant financial risk, specifically noting defaults upon senior securities. The filing also addresses risk factors and the unregistered sale of equity securities.

8-K
8-K
2025-10-29

Tonix Pharmaceuticals filed an 8-K, likely to announce its third-quarter financial results or a material corporate update.

8-K
8-K
2025-10-28
8-K
8-K
2025-10-10
DEF 14A
DEF 14A
2025-10-03
8-K
8-K
2025-09-29
8-K/A
8-K/A
2025-09-17
Data sourced from SEC EDGAR. AI summaries generated automatically.

Past News Coverage

Recent headlines mentioning TONX from our newsroom.

Newest → oldest
Back to All Stocks
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile